Convening of a second Combined General Meeting
at a later date
Paris, France, Cambridge (Massachusetts, United States), June 3, 2022 – 11:00 p.m. – Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a biotechnology company at the clinic specializing in the development of treatments aimed at slowing down the degenerative processes associated with aging and improving the functional results of patients suffering from age-related diseases, informs its shareholders that the Combined Annual General Meeting of June 3, 20022 does not could not deliberate, the quorum not having been reached.
The shareholders taking part in the vote together held 23,514,980 shares, or 15.45% of the capital and 16.19% of the voting rights. The quorum necessary to hold an ordinary general meeting on first call of 20% is not reached and the quorum necessary to hold an extraordinary general meeting on first call of 25% is not reached.